MacroGenics Surpasses Expectations with Q3 Profits
Update: 2025-11-12
Description
MacroGenics Q3 financials exceed expectations, with a net income of $16.8 million and revenue of $72.8 million, surpassing analysts predictions of a loss and a revenue of $28.3 million. This positive performance indicates a successful quarter for the biopharmaceutical firm.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
